NSE: LASA | BSE: 540702

Expensive Underperformer

Download real time

12.67 0.24 (1.93%)

62.17% Fall from 52W High

41,111 NSE+BSE Volume

NSE 09 Jul, 2025 3:31 PM (IST)

63.5

Market Cap

Low in industry

0.9

Beta 1Year

Low volatility

Lasa Supergenerics Ltd. share price target and research reports

Name: Latest research reports of Lasa Supergenerics Ltd. authored by Khambatta Securities and published by - Trendlyne research reports.
Item: Lasa Supergenerics Ltd.
Rating: 5
Author: Khambatta Securities

Latest analyst research reports with target prices and PDF download for LASA, BSE:540702 Lasa Supergenerics Ltd.

Search Inside the pdf :

Lasa Supergenerics Ltd.

25 Aug 2020

12.67

1.93%

Lasa Supergener

Buy: Lasa Supergenerics Ltd.

Khambatta Securities

Increasing prevalence of zoonotic diseases will drive demand for veterinary API products globally. Increasing awareness about preventive animal healthcare and judicious...

Lasa Supergenerics Ltd. has lost -50.80% in the last 1 Year

Lasa Supergenerics Ltd.

04 Jun 2018

12.67

1.93%

STOCK REVIEW NOTE

Hold: Lasa Supergenerics Ltd.

Recommendation Target

Joindre Capital Services

Lasa Supergenerics is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chainfrom discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity For FY18 the company has reported a PAT of Rs 12.32 crs as compared to Rs 2.35 crs last year on a Topline of Rs 249 crs from Rs 220 crs last year. Operating EBIDTA in FY18 totalled Rs 41 crs as compared to Rs 18 crs recorded last year....

Lasa Supergenerics Ltd. has lost -28.42% in the last 3 Months

Lasa Supergenerics Ltd.

14 Dec 2017

12.67

1.93%

LASA SUPERGENERICS LIMITED

Buy: Lasa Supergenerics Ltd.

Joindre Capital Services

Lasa Supergenerics Limited (Lasa) is a vertically integrated player spanning the entire veterinary, animal and human healthcare value chain from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.Lasa is a veterinary API manufacturing entity, which was acquired in April 2012. for around Rs 6 crs. OSCL acquired Lasa as a part of forward integration for some of its chemicals. From a revenue base of less than 10 crs before acquisition, Lasa has reached revenue of Rs 200 crs now The manufacturing base of Lasa is located at Mahad, in the Konkan region of Maharashtra. It specialises in...

Lasa Supergenerics Ltd. has lost -53.04% in the last 6 Months

Is Lasa Supergenerics Ltd. worth buying?

51 Votes:

Buy 76.47%

Sell 17.65%

Hold 5.88%